ReviewFuture oncology (London, England)2026

Evaluating zongertinib in the treatment of patients with HER2-mutant non-small cell lung cancer.

Jinyong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.